High-cost Drugs

The UK plans to boost its spending on expensive cancer drugs by around £160 million ($264 million) over the next two years, increasing its outlay from £200 million a year to £280 million per year, but the government also wants to increase its scrutiny of how well these drugs work for the cost.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Big Prize

Record Amount

At the Front, But…

No Science Post

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.